Características basales y manejo clínico de los primeros 3.000 pacientes incluidos en el estudio IBERICAN (Identificación de la población española de riesgo cardiovascular y renal)

  1. Sergio Cinza Sanjurjo 1
  2. Miguel Ángel Prieto Díaz 2
  3. José Luis Llisterri Caro 3
  4. Vicente Pallarés Carratalá 4
  5. Alfonso Barquilla García 5
  6. Luis Rodríguez Padia 6
  7. Ángel Díaz Rodríguez 7
  8. José Polo García 8
  9. Jesús Vergara Martín 9
  10. Rafael Vidal Pérez 10
  11. Gustavo Cristóbal Rodríguez Roca 11
  1. 1 Centro de Salud de Porto do Son. EOXI Santiago de Compostela, Porto de Son, La Coruña, España
  2. 2 Centro de Salud Vallobín-La Florida, Oviedo, España
  3. 3 Centro de Salud Ingeniero Joaquín Benlloch, Valencia, España
  4. 4 Unión de Mutuas, Castellón, España
  5. 5 Centro de Salud de Trujillo, Trujillo, Cáceres, España
  6. 6 Complejo Hospitalario de Toledo, Toledo, España
  7. 7 Centro de Salud de Bembibre, Bembibre, León, España
  8. 8 Centro de Salud Casar de Cáceres, Casar de Cáceres, Cáceres, España
  9. 9 Centro de Salud de Huércal de Almería, Huércal de Almería, Almería, España
  10. 10 Servicio de Cardiología, Hospital Universitario Lucus Augusti, Lugo, España
  11. 11 Centro de Salud de Puebla de Montalbán, Puebla de Montalbán, Toledo, España
Show affiliations +
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2017

Issue: 7

Pages: 493-500

Type: Article

DOI: 10.1016/J.SEMERG.2016.07.006 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

Objectives To determine the prevalence and incidence of cardiovascular risk factors in Spain, as well as cardiovascular events, in Spanish adult population attended in primary care. Methodology IBERICAN is a longitudinal, observational, multicenter study in which patients aged 18 to 85years attended in primary care health center in Spain are being included. The obtained cohort will be followed annually for at least 5years. The estimated final sample is 7,000 patients. The baseline characteristics of the second cut (n=3,042) are presented. Results The mean age of the subjects included is 57.9±14.6 years, and 55.5% are women. 54.9% live in urban habitat, and 57.3% have primary education. 50.3% had dyslipidemia, 47.4% hypertension, 29.7% physical inactivity, 28.2% abdominal obesity and 19% diabetes mellitus. The degree of control of hypertension, dyslipidemia and type2 diabetes was 58.5%, 25.8% and 75.9%. 28.2% have criteria for metabolic syndrome. 15.6% of patients had previous cardiovascular disease. 7.8% have a history of coronary heart disease, a glomerular filtration rate <60ml/min (CKD-EPI) 8.4%, microalbuminuria 9.6%, atrial fibrillation 5.5%, stroke 4.6%, and heart failure 2.9%. Conclusions Although the population treated in primary care is relatively young, the high prevalence of risk factors, their poor control and the existence of previous cardiovascular disease will determine the impact on the prognosis of the cohort.

Bibliographic References

  • V. Dzau, E. Braunwald Resolved and unresolved issues in the prevention and treatment of coronary artery disease: A workshop consensus statement Am Heart J, 121 (1991), pp. 1244-1263 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • G. Flores-Mateo, M. Grau, M. O’Flaherty, R. Ramos, R. Elosua, C. Violan-Fors, et al. Análisis de la disminución de la mortalidad por enfermedad coronaria en una población mediterránea: España 1988-2005 Rev Esp Cardiol., 64 (2011), pp. 988-996 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P. Mazón-Ramos Riesgo cardiovascular en el siglo xxi. Cómo detectarlo en prevención primaria. Cómo controlarlo en prevención secundaria Rev Esp Cardiol., 65 (Supl 2) (2012), pp. 3-9 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • V. Barrios, C. Escobar, A. Calderón, R. Echarri, V. González-Pedel, L.M. Ruilope, on behalf of the CONTROLRISK Investigators Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study J Hum Hypertension, 21 (2007), pp. 479-485 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Wild, G. Roglic, A. Green, R. Sicree, H. King Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030 Diabetes Care, 27 (2004), pp. 1047-1053 View PDFCrossRefGoogle Scholar
  • P.W. Wilson, R.B. d’Agostino, D. Levy, A.M. Belanger, H. Silbershatz, W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation., 97 (1998), pp. 1837-1847 View PDFView Record in ScopusGoogle Scholar
  • J. Marrugat, I. Subirana, E. Comín, C. Cabezas, J. Vila, R. Elosua, et al. VERIFICA Investigators. Validity of an adaptation of the Framingham cardiovascular risk function: The VERIFICA study J Epidemiol Community Health, 61 (2007), pp. 40-47 View PDFCrossRefView Record in ScopusGoogle Scholar
  • M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2016). The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Eur Heart J. (2016), 10.1093/eurheartj/ehw106 [Epub ahead of print] View PDFGoogle Scholar
  • V. Barrios, C. Escobar, J.L. Llisterri, G. Rodríguez Roca, J.J. Badimón, J. Vergara, et al., representación de los investigadores del estudio IBERICAN Baseline clinical characteristics and management of patients included in IBERICAN study Semergen., 41 (2015), pp. 3-12 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • M. Grau, R. Elosua, A. Cabrera de León, M.J. Guembe, J.M. Baena-Díez, T. Vega Alonso, et al. Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: The DARIOS study Rev Esp Cardiol., 64 (2011), pp. 295-304 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E. Menéndez, E. Delgado, F. Fernández-Vega, M.A. Prieto, E. Bordiú, A. Calle, et al. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es Rev Esp Card, 69 (2016), pp. 572-578 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • F. Soriguer, A. Goday, A. Bosch-Comas, E. Bordiú, A. Calle-Pascual, R. Carmena, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study Diabetologia., 55 (2012), pp. 88-93 View PDFCrossRefView Record in ScopusGoogle Scholar
  • S. Valdés, F. García-Torres, C. Maldonado-Araque, A. Goday, A. Calle-Pascual, F. Soriguer, et al. Di@bet.es study group. Prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es study Rev Esp Cardiol (Engl Ed)., 67 (2014), pp. 442-448 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.L. Llisterri, G.C. Rodríguez-Roca, F.J. Alonso, M.A. Prieto, J.R. Banegas, D. González-Segura Alsina, et al. Control de la presión arterial en la población hipertensa española asistida en Atención Primaria. Estudio PRESCAP 2010 Med Clin (Barc)., 139 (2012), pp. 653-661 Google Scholar
  • J.L. Llisterri, G.C. Rodriguez-Roca, C. Escobar, F.J. Alonso-Moreno, M.A. Prieto, V. Barrios, et al. Treatment and blood pressure control in Spain during 2002-2010 J Hypertens., 30 (2012), pp. 2425-2431 View Record in ScopusGoogle Scholar
  • J.M. Baena-Díez, F.J. Félix, M. Grau, A. Cabrera de León, H. Sanz, M. Leal, et al. Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study Rev Esp Cardiol., 64 (2011), pp. 766-773 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P. Guallar-Castillón, M. Gil-Montero, L.M. León-Muñoz, A. Graciani, A. Bayán-Bravo, J.M. Taboada, et al. Magnitud y manejo de la hipercolesterolemia en la población adulta de España, 2008-2010, el estudio ENRICA Rev Esp Cardiol., 65 (2012), pp. 551-558 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.R. Banegas, E. López-García, J. Dallongeville, E. Guallar, J.P. Halcox, C. Borghi, et al. Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study Int J Cardiol., 166 (2011), pp. 210-214 Google Scholar
  • D. Fernández-Bergés, A. Cabrera de León, H. Sanz, R. Elosua, M.J. Guembe, M. Alzamora, et al. Metabolic syndrome in Spain: Prevalence and coronary risk associated with harmonized definition and WHO proposal. DARIOS study Rev Esp Cardiol., 65 (2012), pp. 241-248 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P. Guallar-Castillón, R.F. Pérez, E. López García, L.M. León-Muñoz, M.T. Aguilera, A. Graciani, et al. Magnitude and management of metabolic syndrome in Spain in 2008-2010: The ENRICA study Rev Esp Cardiol., 67 (2014), pp. 367-373 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • E. Ortega, A.J. Amor, G. Rojo-Martínez, C. Castell, M. Giménez, I. Conget Cardiovascular disease in patients with type 1 and type 2 diabetes in Spain Med Clin (Barc)., 145 (2015), pp. 233-238 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J.F. Cano, J.M. Baena-Diez, J. Franch, J. Vila, S. Tello, J. Sala, et al. REGICOR and GEDAPS Investigators. Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: A population based cohort study in southern Europe Diabetes Care., 33 (2010), pp. 2004-2009 View PDFCrossRefView Record in ScopusGoogle Scholar
Data source: Dialnet